These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34496552)
21. Formulation and Optimization of Alogliptin-Loaded Polymeric Nanoparticles: In Vitro to In Vivo Assessment. Mohanty D; Gilani SJ; Zafar A; Imam SS; Kumar LA; Ahmed MM; Jahangir MA; Bakshi V; Ahmad W; Eltayib EM Molecules; 2022 Jul; 27(14):. PubMed ID: 35889343 [TBL] [Abstract][Full Text] [Related]
22. Formulation and optimization of doxorubicin loaded polymeric nanoparticles using Box-Behnken design: ex-vivo stability and in-vitro activity. Shaikh MV; Kala M; Nivsarkar M Eur J Pharm Sci; 2017 Mar; 100():262-272. PubMed ID: 28126560 [TBL] [Abstract][Full Text] [Related]
23. Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture. Sunoqrot S; Alfaraj M; Hammad AM; Kasabri V; Shalabi D; Deeb AA; Hasan Ibrahim L; Shnewer K; Yousef I Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32867015 [TBL] [Abstract][Full Text] [Related]
24. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
25. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability. Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462 [TBL] [Abstract][Full Text] [Related]
26. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation. Mehta AK; Yadav KS; Sawant KK Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492 [TBL] [Abstract][Full Text] [Related]
27. Development and optimization of locust bean gum and sodium alginate interpenetrating polymeric network of capecitabine. Upadhyay M; Adena SKR; Vardhan H; Pandey S; Mishra B Drug Dev Ind Pharm; 2018 Mar; 44(3):511-521. PubMed ID: 29161913 [TBL] [Abstract][Full Text] [Related]
28. QbD based development of proliposome of lopinavir for improved oral bioavailability. Patel GM; Shelat PK; Lalwani AN Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019 [TBL] [Abstract][Full Text] [Related]
30. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats. Rahman MA; Harwansh RK; Iqbal Z Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786 [TBL] [Abstract][Full Text] [Related]
31. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
32. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments. Simonoska Crcarevska M; Geskovski N; Calis S; Dimchevska S; Kuzmanovska S; Petruševski G; Kajdžanoska M; Ugarkovic S; Goracinova K Eur J Pharm Sci; 2013 Apr; 49(1):65-80. PubMed ID: 23439240 [TBL] [Abstract][Full Text] [Related]
33. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Kola Srinivas NS; Verma R; Pai Kulyadi G; Kumar L Int J Nanomedicine; 2017; 12():15-28. PubMed ID: 28031710 [TBL] [Abstract][Full Text] [Related]
34. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472 [TBL] [Abstract][Full Text] [Related]
35. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design. Gajra B; Patel RR; Dalwadi C Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522 [TBL] [Abstract][Full Text] [Related]
36. Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam. Bhatia M; Rohilla S Saudi Pharm J; 2020 Aug; 28(8):927-935. PubMed ID: 32792837 [TBL] [Abstract][Full Text] [Related]
37. Preparation and Biopharmaceutical Evaluation of Novel Polymeric Nanoparticles Containing Etoposide for Targeting Cancer Cells. Thiyagarajan A; Saravanabhavan S; Thangarasu V Turk J Pharm Sci; 2019 Jun; 16(2):132-140. PubMed ID: 32454706 [TBL] [Abstract][Full Text] [Related]
38. Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect. Venkatesh DN; Baskaran M; Karri VV; Mannemala SS; Radhakrishna K; Goti S Saudi Pharm J; 2015 Nov; 23(6):667-74. PubMed ID: 26702262 [TBL] [Abstract][Full Text] [Related]
39. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology. Gajera BY; Shah DA; Dave RH Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724 [TBL] [Abstract][Full Text] [Related]
40. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and Akhter MH; Kumar S; Nomani S Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]